NetworkNewsAudio Archive - Page 4 of 43

FridayMay 31, 2024 7:50 am

Torr Metals Inc. (TSX.V: TMET) Featured in Syndicated Broadcast Covering Significant Increase in Sizing of Kolos Copper-Gold Project

Related Press Release Torr Metals Inc. (TSX.V: TMET) has significantly increased the size of its British-Columbia-based Kolos Copper-Gold Project by 75% from an approximate 140 km to 240 km. The company announced that new mineral claims focus on northern expansion, following an extension of the north-trending Fanta Fault, an orientation identified by the company as a major structural control on copper (Cu) and gold (Au) mineralization in the area. “By securing these new claims at low cost, we've strategically expanded our footprint to include highly prospective ground to the east and north, incorporating the historical Ram soil anomaly as well…

MondayMay 13, 2024 8:00 am

NetworkNewsAudio – DeFi Technologies (NEO: DEFI) (OTC: DEFTF) Subsidiary Reports AUM Increase of 47.2% to C$748 Million

Related Press Release DeFi Technologies Inc. (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF), a crypto native technology company that pioneers the convergence of traditional capital markets with the world of decentralized finance, recently announced that its subsidiary, Valour Inc., and Valour Digital Securities Limited (together, “Valour”), a leading issuer of exchange traded products (“ETPs”) that provide simplified access to digital assets, reported a 47.2% year-over-year increase of assets under management ("AUM") to C$748 million as of May 7, 2024. The news release also noted other key developments such as the launch of a new trading desk in the United Arab Emirates,…

MondayApr 29, 2024 7:00 am

NetworkNewsAudio – Torr Metals Inc. (TSX.V: TMET) Confirms Kilometre-Scale Geophysical Anomalies Coincident with Untested Copper Porphyry Targets at Kolos

Torr Metals Inc. (TSX.V: TMET) is very pleased to announce preliminary results that have identified near-surface high priority geophysical resistivity anomalies extending up to >1.5 kilometers (km) depth that are coincident with highly anomalous copper (Cu), gold (Au), and molybdenum (Mo) mineralization at-surface. These compelling exploration drill targets have been identified using a newly completed 3D resistivity inversion voxel model, derived from the ZTEM geophysical survey completed over the entirety… To view the full press release, visit https://nnw.fm/qul5u About Torr Metals Inc. Torr Metals is a Vancouver-based mineral exploration company focused on defining and developing the substantial exploration potential of the…

TuesdayFeb 27, 2024 8:00 am

NetworkNewsAudio – Diamond Lake Minerals Announces Strategic Investment in Avrio Worldwide, PBC

Related Press Release Diamond Lake Minerals, Inc. (OTC: DLMI) recently made a strategic investment in Avrio Worldwide, PBC to support deployment of Avrio’s registered digital financial market infrastructure (dFMI) for the tokenization of digital assets across DLMI’s network of companies. Avrio is the parent of several companies delivering licensed digital financial market infrastructure and services across public, private and digital markets. “DLMI’s strategic investment in Avrio offers outstanding opportunities and synergies across the DLMI network of companies for the tokenization of real-world-assets (RWA) on Avrio’s registered dFMI, as well as opportunities to invest in Avrio’s companies and commercial partners that…

TuesdayFeb 20, 2024 7:55 am

NetworkNewsAudio – Nextech3D.ai Launches Next Era of GPT AI 3D Solutions Led by Former Microsoft Executive

Related Press Release Nextech3D.AI (OTCQX:NEXCF) (CSE:NTAR) (FSE:1SS) recently announced that it is launching the next era of GPT AI 3D product solutions of proprietary Artificial Intelligence (AI) algorithms. The initiative will be led by former Microsoft Executive Hareesh Achi, who is Nextech3D.ai's current Head of Product Operations. The Company believes that the AI opportunity is in the early stages, and that the shift from 2D to 3D modeling for e-commerce is part of a major multi-decade transformation that is being led by AI. The Company is working on annual enterprise licensing deals for its suite of GPT AI solutions for…

FridayFeb 16, 2024 8:30 am

NetworkNewsAudio – Vision Marine Technologies Inc. (NASDAQ: VMAR) Leading Out in ‘Revolutionizing’ Recreational Boating Space

Related Editorial The raucous rumble of combustion engines is fading, systematically replaced by the high-performance hum of electric propulsion that’s transforming every aspect of transport. Electric cars have moved mainstream with both automakers and upstarts offering multiple mobility options. Now another market is being disrupted, as sleek electric boats glide across the water leaving nothing but a whisper of ripples in their wake. This surge in electrification isn't just about a clean and green conscience; it's about performance, convenience and a technological transition in mobility that may be as profound as the shift from the horse to the horseless carriage.…

WednesdayJan 17, 2024 3:00 am

NetworkNewsAudio – Alarum Estimates Record Revenue and All Time High Operating Cashflow for the Fourth Quarter of 2023

Related Press Release Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of internet access and web data collection solutions, recently announced that it anticipates reporting record revenue and operating cashflow for the fourth quarter of 2023. The Company estimates that $2.8 million in cashflow from operating activities was generated for the quarter, compared to a negative cashflow of approximately $1.8 million for the same period a year earlier. With total expected revenue for last year estimated at $26.5 million, Alarum anticipates an increase of approximately 41% compared to the total revenue of 2022. Furthermore, it…

ThursdayJan 11, 2024 8:30 am

NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) Looks to Supercharge Reach, Impact of GLP-1 Agonists with Proprietary Drug-Delivery Solution

Related Editorial Already proven to be a revolutionary treatment for type 2 diabetes and weight loss, glucagon-like peptide-1 (GLP-1) agonists now appear to have a multitude of potential blockbuster therapeutic uses, according to recent research. Obviously, diabetes remains a primary indication, given the massive global need. However, the impact of this extraordinary molecule extends far beyond type 2 diabetes. The reach of GLP-1 drugs has widened in ways its inventors likely never imagined. Clinical trials are underway testing GLP-1 drugs to treat Alzheimer’s, Parkinson’s, and even drug addiction, plus there are strong indications of therapeutic efficacy in heart disease and…

FridayNov 17, 2023 7:55 am

NetworkNewsAudio – PaxMedica Inc. (NASDAQ: PXMD) Holds Important FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data

Related Press Release PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company, announced the completion of a type-B meeting with the FDA. During the live meeting, the company discussed the positive results of the recent data from its PAX-HAT-301 study of suramin in Stage One Human African Sleeping Sickness caused by Trypanosoma brucei rhodesiense, a rare and fatal parasitic disease if left untreated. To view the original press release, visit https://nnw.fm/CcN9z About PaxMedica Inc. PaxMedica is a forward-looking, clinical-stage biopharmaceutical firm specializing in cutting-edge anti-purinergic drug therapies (“APT”) aimed at addressing a range of challenging neurologic disorders. The company’s comprehensive portfolio encompasses a…

ThursdayNov 02, 2023 8:30 am

NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Impact of Exclusive Drug-Delivery Solution on GLP-1 Drugs

Related Editorial The prestigious New England Journal of Medicine recently published results of a large study of 2,539 adults wherein weight loss of 49 to 52 pounds was a common outcome. With more than 37 million Americans suffering from diabetes, and with obesity at epidemic levels, it’s little wonder that millions of people are singing their praises of the new class of drugs responsible for these outrageously positive outcomes. GLP-1 agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with type 2 diabetes but are also helping treat obesity. Seems everyone is excited…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsAudio